ASTM E 2661/E2661M : 2010

1.1 This practice covers acoustic emission (AE) examination or monitoring of panel and plate-like composite structures made entirely of fiber/polymer composites.

1.2 The AE examination detects emission sources and locates the region(s) within the composite structure where the emission originated. When properly developed AE-based criteria for the composite item are in place, the AE data can be used for nondestructive examination (NDE), characterization of proof testing, documentation of quality control or for decisions relative to structural-test termination prior to completion of a planned test. Other NDE methods may be used to provide additional information about located damage regions. For additional information see Appendix X1.

1.3 This practice can be applied to aerospace composite panels and plate-like elements as a part of incoming inspection, during manufacturing, after assembly, continuously (during structural health monitoring) and at periodic intervals during the life of a structure.

1.4 This practice is meant for fiber orientations that include cross-plies, angle-ply laminates or two-dimensional woven fabrics. This practice also applies to 3-D reinforcement (for example, stitched, z-pinned) when the fiber content in the third direction is less than 5 % (based on the whole composite).

1.5 This practice is directed toward composite materials that typically contain continuous high modulus greater than 20 GPa [3 Msi] fibers.

1.6 The values stated in either SI units or inch-pound units are to be regarded separately as standard. The values stated in each system may not be exact equivalents; therefore, each system shall be used independently of the other. Combining values from the two systems may result in non-conformance with the standard.

1.7 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.